BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
Journal of the National Cancer Institute
|November 21, 2015
Summary
The BRCA2 K3326X variant increases breast and ovarian cancer risks, independent of other BRCA2 mutations. This finding is crucial for understanding genetic predispositions to hormone-related cancers.
Area of Science:
- Genetics
- Oncology
- Cancer Epidemiology
Background:
- The BRCA2 K3326X variant (rs11571833) shows a slight association with breast cancer risk.
- The role of K3326X in other hormone-related cancers and its independence from pathogenic BRCA2 mutations remain unclear.
Purpose of the Study:
- To evaluate the association of the BRCA2 K3326X variant with breast, ovarian, and prostate cancer risks.
- To investigate the K3326X variant's effect on cancer risk in BRCA1 mutation carriers.
Main Methods:
- Weighted logistic regression analysis of the iCOGS dataset (76,637 cases, 83,796 controls).
- Cox proportional hazards modeling for K3326X associations in 7,183 BRCA1 variant carriers.
- Odds ratios (ORw) and hazard ratios (HR) with 95% confidence intervals (CIs) were calculated.
Main Results:
- K3326X is associated with increased breast (ORw=1.28) and invasive ovarian cancer (ORw=1.26) risk.
- Stronger associations observed for serous ovarian and ER-negative breast cancers.
- In BRCA1 carriers, K3326X showed an inverse association with ovarian cancer risk (HR=0.43).
Conclusions:
- The BRCA2 K3326X variant independently contributes to breast and ovarian cancer risk.
- Further research is required to elucidate the underlying biological mechanisms.
Related Concept Videos
01:20The Retinoblastoma Gene
4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
01:20The Retinoblastoma Gene
2.8K
2.8K
01:33Cancer-Critical Genes I: Proto-oncogenes
11.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.9K
01:33Cancer-Critical Genes I: Proto-oncogenes
6.1K
6.1K
02:38The Ras Gene
7.5K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.5K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
3.0K
3.0K